amphetamine has been researched along with Fatigue Syndrome, Chronic in 1 studies
Amphetamine: A powerful central nervous system stimulant and sympathomimetic. Amphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulation of release of monamines, and inhibiting monoamine oxidase. Amphetamine is also a drug of abuse and a psychotomimetic. The l- and the d,l-forms are included here. The l-form has less central nervous system activity but stronger cardiovascular effects. The d-form is DEXTROAMPHETAMINE.
1-phenylpropan-2-amine : A primary amine that is isopropylamine in which a hydrogen attached to one of the methyl groups has been replaced by a phenyl group.
amphetamine : A racemate comprising equimolar amounts of (R)-amphetamine (also known as levamphetamine or levoamphetamine) and (S)-amphetamine (also known as dexamfetamine or dextroamphetamine.
Fatigue Syndrome, Chronic: A syndrome characterized by persistent or recurrent fatigue, diffuse musculoskeletal pain, sleep disturbances, and subjective cognitive impairment of 6 months duration or longer. Symptoms are not caused by ongoing exertion; are not relieved by rest; and result in a substantial reduction of previous levels of occupational, educational, social, or personal activities. Minor alterations of immune, neuroendocrine, and autonomic function may be associated with this syndrome. There is also considerable overlap between this condition and FIBROMYALGIA. (From Semin Neurol 1998;18(2):237-42; Ann Intern Med 1994 Dec 15;121(12): 953-9)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Chronic fatigue is a complex and little understood symptom for which there is no safe and effective pharmacotherapy." | 5.33 | Trichopus zeylanicus combats fatigue without amphetamine-mimetic activity. ( Brown-Borg, HM; Dhanasekaran, M; Manyam, BV; Tharakan, B, 2006) |
| "Chronic fatigue is a complex and little understood symptom for which there is no safe and effective pharmacotherapy." | 1.33 | Trichopus zeylanicus combats fatigue without amphetamine-mimetic activity. ( Brown-Borg, HM; Dhanasekaran, M; Manyam, BV; Tharakan, B, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tharakan, B | 1 |
| Dhanasekaran, M | 1 |
| Brown-Borg, HM | 1 |
| Manyam, BV | 1 |
1 other study available for amphetamine and Fatigue Syndrome, Chronic
| Article | Year |
|---|---|
Trichopus zeylanicus combats fatigue without amphetamine-mimetic activity.
Topics: Amphetamine; Analysis of Variance; Animals; Behavior, Animal; Chronic Disease; Dioscoreaceae; Fatigu | 2006 |